Search results for: 'care development'
- Related search terms
- development startup and future trend of ophthalmic drugs market
- care management solutions market by components
- development states and future trend of ophthalmic drugs market
- development startup ad future trend of ophthalmic drugs market
- care market research
-
09 Apr 2024  |  North America  |  Market Research
US and European Home Care Digitalization Growth Opportunities Forecast to 2028
Technology will Support Consumer Preferences for Receiving Care in the Comfort of Home
Home has become an attractive care delivery site because of the convenience, affordability, and patient-centric care environment it offers. The home care digitalization industry represents technologies that home care agencies use to improve/enhance services for the end user (B2B2C). The industry picked up pace during the COVID-19 pandemic and has s...
$4,950.00
Special Price $3,712.50 save 25 %
-
01 Jul 2016  |  Europe  |  Market Research
Western Europe Point-of-Care Testing (POCT) Market
Point-of-care testing is an integral part of the IVD market that is rapidly evolving into a preferred testing mode in the EU region. POCT is a segment that presents growth opportunities for a cross-section of players, ranging from OEMs to data integrators to technology vendors. The stakeholders need to be abreast of the challenges posed by the indu...
$4,950.00
Special Price $3,712.50 save 25 %
-
24 Jul 2024  |  Global  |  Technology Research
Menopause Care Management Technology Growth Opportunities, 2024 2029
Growing competitive intensity fuels future growth potential in menopause care management
As the global population ages, more attention should be paid to the needs of individuals aged 45 to 55, particularly women in the perimenopausal and menopausal stages. Women aged 45 and above are at a crucial stage in terms of professional and personal responsibilities; however, they are challenged by menopausal symptoms, such as hot flashes, sleep...
$4,950.00
Special Price $3,712.50 save 25 %
-
25 Jun 2024  |  Global  |  Market Research
Growth Opportunities in Biologics Contract Development and Manufacturing Organizations, 2024 2029
Risk-sharing Business Models for Next-generation Biologics Will Drive Bio-CDMO Growth and Spur Future Potential
By 2023, biologics constituted 44% of the therapeutic pipeline, with antibodies and recombinant proteins as leading categories. Nevertheless, advancements in these fields decelerated, with most of the expansion happening in heterologous cell treatments, synthetic nucleic acids, and viruses. The global biologics pipeline will shift toward more compl...
$4,950.00
Special Price $3,712.50 save 25 %
-
19 Dec 2023  |  North America  |  Market Research
Growth Opportunities in US Digital Health Solutions as an Enabler for Value-based Care
Robust Investments and Disruptive Technological Innovation Transforming Care Delivery
According to the Centers for Medicare and Medicaid Services (CMS), value-based care (VBC) programs reward healthcare providers with incentive payments for the quality of care they provide Medicare patients. These programs are part of its larger CMS quality strategy to reform healthcare delivery and payment. Value-based programs support 3 aims: b...
$2,450.00
Special Price $1,837.50 save 25 %
-
14 Sep 2020  |  North America  |  Market Research
Smartphone-based Solutions Spur the Global Infectious Disease Point-of-Care Testing Market, Forecast to 2024
COVID-19 and STDs among Millennials Speed Development of Miniaturized POCT Devices and Alternate Care Sites to Enable Transformational Growth
The COVID-19 pandemic prompted a transformation in the infectious disease point-of-care testing (POCT) market. The shift towards miniaturized POCT devices will lead to the emergence of cost-effective integrated lab-on-a-chip devices based on microfluidic technologies and smartphone-based solutions enabling multiplexed detection of infectious pathog...
$4,950.00
Special Price $3,712.50 save 25 %
-
16 Aug 2021  |  North America  |  Market Research
Global Drug Discovery and Early Development Outsourcing Growth Opportunities
Growing Research and Development Pipelines of Emerging Biopharmaceutical and Niche Technology Providers Drive Competitive Intensity
Frost & Sullivan presents post-COVID-19 growth opportunities and strategic imperatives for the global drug discovery and early development outsourcing market in this study, which covers research and development (R&D) efforts, market trends, key participants, drivers and restraints of market adoption, and recent mergers and acquisitions. The report ...
$4,950.00
Special Price $3,712.50 save 25 %
-
17 Jun 2021  |  North America  |  Market Research
Global Biologics Contract Development and Manufacturing Organizations Growth Opportunities
Asset Co-Development with Clinical-stage Biopharmaceutical Companies and Disruptive Technologies Present Future Growth Potential
This study presents Frost & Sullivans overall market and segment-wise revenue forecasts of the global biologics contract development and manufacturing organizations (bio-CDMO) market. It also highlights key growth opportunities for bio-CDMO market participants based on the main evolution in their business models and strategic approaches, as well as...
$4,950.00
Special Price $3,712.50 save 25 %
-
17 Dec 2019  |  Global  |  Technology Research
Emerging Microbiome Technologies for Applications in Skin Care
Microbiome-based Innovations Transforming the Personal Care Landscape
Skin microbiome industry has been rapidly evolving since the past few years and is likely to witness new innovations in the near future. Apart from emerging new start-ups in this area, several leading cosmetic and industry participants are likely to shift focus towards emerging microbiome-based beauty platforms.As the consumer focuses towards the...
$4,950.00
Special Price $3,712.50 save 25 %
-
15 Feb 2022  |  North America  |  Market Research
Global Biologics Contract Development and Manufacturing Organization Profiles and Growth Opportunities
The Contract Research, Development, and Manufacturing Organization Business Model to Drive Future Growth Potential
Frost & Sullivan provides comprehensive insights into the global biologics contract development and manufacturing organization (bio-CDMO) market, including emerging trends, growth opportunities, and profiles of leading bio-CDMOs and their business model evolution. The growth of next-generation biologics and personalized therapies and the emergence ...
$2,450.00
Special Price $1,837.50 save 25 %